SR One Ltd.

About The Fund

SR One Ltd. is a venture capital firm headquartered at One Broadway, Cambridge, Massachusetts. As an investor with a focus on the biotechnology, medical devices, life science, and related sectors, SR One Ltd. engages in the art of equity investments, particularly emphasizing early-stage companies within these industries. With assets under management amounting to $600 million, the fund supports innovative ventures that show promise in developing advanced treatments and technologies within the life sciences field. The investment thesis of SR One centers on identifying and nurturing companies that demonstrate potential for significant impact on patient care through novel approaches to tackling medical challenges. SR One Ltd.'s specialization lies in leveraging their deep domain expertise to assist portfolio companies in maturing their scientific discoveries into meaningful healthcare solutions. Furthermore, as a venture capital fund, SR One Ltd.'s primary role is to provide capital and strategic support to help portfolio companies navigate the complex landscape of healthcare innovation, from inception through the various stages of growth and development. The fund’s commitment to fostering innovation in healthcare is rooted in a thorough understanding of the dynamic and evolving nature of the life sciences field, wherein it endeavours to deliver both impactful healthcare outcomes and financial returns to its stakeholders.